Topics

• ANTITRUST

• Asset Management

• Data, Privacy & Cybersecurity

• Digital Health

• Employee Benefits/ERISA

• Enforcement

• False Claims Act

• FDA REGULATORY

• Health Care

• Intellectual Property

• PRIVATE EQUITY

• TAX

Capital Insights

Analysis

• Lummis-Gillibrand Digital Asset Bill – Key Takeaways
  (June 17, 2022)
• Russia/Ukraine Crisis: U.S. Sanctions Escalation Continues
  (May 9, 2022)
• Russia/Ukraine Crisis: U.S. Imposes Significant New Sanctions in Response to Russian Atrocities in Ukraine
  (April 8, 2022)
• Podcast - Talkin' Trade: Enforcement of Section 337 Exclusion Orders at U.S. Customs and Border Protection
  (April 7, 2022)
• Podcast - Non-binding Guidance: Real-World Evidence in Drug Development
  (March 30, 2022)

In The News

• In Modern Healthcare, Margaux Hall Discusses FTC Investigation of Pharmacy Benefit Managers
  (June 16, 2022)
• In Technology Transfer Tactics Health Care Attorneys Analyze HHS Opinion Clarifying Anti-Kickback Rules for Physician Inventors
  (May 19, 2022)
• In Law360, Attorneys Examine CMS Changes Coming to Medicare Part D Market 
  (May 18, 2022)
• Chambers Cybersecurity 2022 USA Chapter Authored by Ed McNicholas, Fran Faircloth and Kevin Angle 
  (April 8, 2022)
• In Bloomberg Law, Scott McKeown Examines Confirmation of New USPTO Director
  (April 8, 2022)